IP Verse

Pneumococcal Polysaccharide Conjugate Vaccine - EP3017827

The patent EP3017827 was granted to Glaxosmithkline on Nov 7, 2018. The application was originally filed on Dec 20, 2006 under application number EP15195398A. The patent is currently recorded with a legal status of "Revoked".

EP3017827

GLAXOSMITHKLINE
Application Number
EP15195398A
Filing Date
Dec 20, 2006
Status
Revoked
Apr 4, 2025
Grant Date
Nov 7, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PFIZERAug 6, 2019PFIZER -
SANOFI PASTEUR INCSANOFI AVENTIS DEUTSCHLAND GMBHSANOFI WINTHROP INDUSTRIESAug 6, 2019ZWICKER -
SK BIOSCIENCEAug 6, 2019ZWICKER -

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
OPPOSITIONEP0072513
OPPOSITIONEP0497524
OPPOSITIONEP0497525
OPPOSITIONEP3017827
OPPOSITIONUS4619828
OPPOSITIONUS5565204
OPPOSITIONWO03051392
OPPOSITIONWO2006110381
OPPOSITIONWO2010080484
OPPOSITIONWO9508348
SEARCHUS2003147922
SEARCHWO03051392
SEARCHWO2006110381

Non-Patent Literature (NPL) Citations (13) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- DE LA PEÑA et al., Pediátrika, (20040000), vol. 24, no. 4, pages 147 - 155, XP055162952-
OPPOSITION- DE LA PENA et al., "presente y futuro de la vacunacion antineumococica", Pediatrika, (20040000), vol. 24, no. 4, pages 147 - 155, XP055162952-
OPPOSITION- GATCHALIAN et al., "A RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE IMMUNOGENICITY OF AN 11-V ALENT PNEUMOCOCCAL PROTEIN D CONJUGATE VACCINE ADMINISTERED AS PRIMARY VACCINATION TO INFANTS AT 6, 10 AND 14 WEEKS OF AGE", 17th Annual Meeting of the European Society of Pediatric Infectious Disease (ESPID), poster number 4, P1APoster Session 1, Istanbul Turkey, (20010000), XP055629131-
OPPOSITION- MOORE MATHEW R, Epidemiology of invasive pneumococcal disease in adults, (20051117), XP002438871-
OPPOSITION- REINGOLD et al., "Replacement Pneumococcal Disease: Increase in Non-Vaccine Type Disease in the Era of Widespread Pneumococcal Conjugate Vaccination", Replacement Pneumococcal Disease: Increase in Non-Vaccine Type Disease in the Era of Widespread Pneumococcal Conjugate Vaccination, (20051006), URL: https://idsa.confex.com/i dsa/2005/webprog ram/Paper20882.hlml, XP055629135-
OPPOSITION- MACNAIR J E. et al., Bioloicals, (20050301), vol. 33, no. 1, pages 49 - 58, XP004745183
OPPOSITION- TONTINI M et al., "Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines", Vaccine, (20130000), vol. 31, pages 4827 - 4833, XP028717057
OPPOSITION- PECETTA S et al., "Carrier priming with CRM197or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: Biophysical and immunochemical interpretation", Vaccine, (20150000), vol. 33, pages 314 - 320, XP029117301
OPPOSITION- ANDERSON P. et al., "- Non-interference between two protein carriers when used with the same polysaccharide for pneumococcal conjugate vaccines in 2-year-old children", Vaccine, (20030000), vol. 21, pages 1554 - 1559, XP004412495
OPPOSITION- FATTOM A et al., "Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines", Vaccine, (19990000), vol. 17, pages 126 - 133, XP004139967
OPPOSITION- ADA G et al., Clinical Microbiology and Infection, (20030000), vol. 9, no. 2, pages 79 - 85, XP002415010
OPPOSITION- OBARO et al., "SAFETY AND IMMUNOGENECITIY OF A NONAVALENT PNEUMOCOCCAL VACCINE CONJUGATED TO CRM197 ADMINISTERED SIMULTANEOUSLY BUT IN A SEPARATE SYRINGE WITH DIPHTHERIA, TETANUS AND PERTUSSIS VACCINES IN GAMBIAN INFANTs", Pediatric Infectious Diseases Journal, (20000000), vol. 19, pages 463 - 469, XP008067219
OPPOSITION- OBARO et al., "Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants", Pediatric Infectious Diseases Journal, (20000000), vol. 19, pages 463 - 469, XP008067219

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents